HomeAI · summaries
Storia in 2 fonti
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
- ·
endpoints.news
Takeda builds case around leading orexin program with new Phase 3 data
With a formidable new competitor set to enter the orexin development race, Takeda is out with new data it hopes reinforces market-leading potential.